HCA Healthcare Inc. HCA reported on Friday that first-quarter 2025 revenues have been $18.32 billion, up 6% year-over-year, barely above the consensus of $18.26 billion.
The hospital chain reported adjusted EPS of $6.45, up from $5.36 a yr in the past, surpassing the consensus of $5.76.
Within the first quarter of 2025, same-facility admissions elevated by 2.6%, and same-facility equal admissions elevated by 2.8%.
- Identical facility emergency room visits elevated by 4%.
- Identical-facility inpatient surgical procedures elevated by 0.2%, and same-facility outpatient surgical procedures declined by 2.1%.
- Identical facility income per equal admission elevated 2.9% in comparison with the primary quarter of 2024.
Additionally Learn: Zoom Faces International Growth Risks Amid Macroeconomic And Tariff Headwinds: Analyst
HCA Healthcare CEO Sam Hazen mentioned the corporate stays “inspired” by the general backdrop of rising demand for healthcare providers.
Web earnings attributable to HCA Healthcare totaled $1.61 billion in comparison with $1.591 billion a yr in the past.
Adjusted EBITDA reached $3.73 billion within the first quarter of 2025, in comparison with $3.353 billion within the first quarter of 2024.
Steerage: HCA Healthcare reaffirms 2025 EPS of $24.05-$25.85 versus a consensus of $24.97 and a sales outlook of $72.8 billion—$75.8 billion versus a consensus of $74.63 billion.
The corporate’s steerage included its present expectations concerning quantity development coupled with an anticipated principally secure working surroundings, payer combine, the continuing impacts of the 2 main 2024 hurricanes, the influence of present and future well being care public coverage developments, in addition to normal enterprise or financial situations, together with inflation, and the influence of commerce insurance policies, together with tariffs.
Worth Motion: HCA Healthcare inventory is down 0.463% at $323.86 ultimately verify Friday.
Learn Subsequent:
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
